3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
67
Pancreatic Neoplasms
34
Neoplasm Metastasis
22
Neuroblastoma
21
Neoplasms
16
Colonic Neoplasms
15
Stomach Neoplasms
13
Rectal Neoplasms
13
Sarcoma, Ewing
8
Rhabdomyosarcoma
8
Esophageal Squamous Cell Carcinoma
8
Small Cell Lung Carcinoma
7
Sarcoma
7
Ovarian Neoplasms
6
Lung Neoplasms
6
Cholangiocarcinoma
6
Esophageal Neoplasms
5
Breast Neoplasms
5
Adenocarcinoma Of Esophagus
5
Medulloblastoma
4
Gastrointestinal Neoplasms
4
Endometrial Neoplasms
4
Biliary Tract Neoplasms
4
Adenocarcinoma
4
Recurrence
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Osteosarcoma
3
Glioma
3
Glioblastoma
3
Ganglioneuroblastoma
3
Interventions
Gemcitabine
2
130-nm albumin-bound paclitaxel
2
Oxaliplatin
1
Leucovorin
1
Irinotecan
1
Fluorouracil
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Locally Advanced Pancreatic Cancer
×
Irinotecan
×
1 year
×
Clear all
NCT05466799
2026-02-13
TRIPP-FFX
OncoSil Medical Limited
Phase 2
Active not recruiting
88 enrolled